SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-277893
Filing Date
2023-11-15
Accepted
2023-11-15 16:11:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d561116d424b5.htm 424B5 167158
2 GRAPHIC g561116g05d52.jpg GRAPHIC 57184
3 GRAPHIC g561116g10k06.jpg GRAPHIC 174251
  Complete submission text file 0001193125-23-277893.txt   477846
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275307 | Film No.: 231410673
SIC: 2834 Pharmaceutical Preparations